OncobiotaLUNG is a minimally invasive and high-precision microbiome-driven liquid biopsy™ method is designed to help detect cancer even in its earliest stages. Micronoma’s patent-pending method, analyzing a multitude of circulating microbial markers linked to the tumor tissue as well as the host response to the cancer, has the potential to provide an advantage in early-stage cancer detection.